ArticleBreast cancer (Dove Medical Press)2025

Inavolisib-Based Therapy for PIK3CA-Mutated Advanced Male Breast Cancer: A Cost-Effectiveness Analysis.

Xiaoting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.